NCT06470659Completed
Medications With or Without WeightWatchers
Effectiveness of a Telehealth Medical Weight Management Program Prescribing Anti-obesity Medications Paired With a Digital Behavioral Weight Management Program
Source: ClinicalTrials.gov · Last updated 3 Apr 2025
Brief summary (registry, in English)
The study compares the effectiveness of adults living with overweight or obesity taking weight management medications alone vs taking them with behavioral and lifestyle support. The primary outcome is percent body weight lost at 12-weeks.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 101 (actual)
- First submitted
- 14 Jun 2024
- Start date
- 17 Jun 2024
- Primary completion date
- 28 Jan 2025
- Lead sponsor
- Michelle Cardel, PhD, MS, RD
- Diseases
- Obesity
- NCT number
- NCT06470659
What you commit to
- Study type: Interventional
- Participants enrolled: 101
- From 17 Jun 2024 to the primary completion date, 28 Jan 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Currently taking bupropion
- Currently taking naltrexone
- Current or previous history of anorexia or bulimia nervosa
- Currently taking opioids
- Previous surgical obesity treatment
- Use of other anti-obesity medication in last 90 days or a GLP1 in the last 180 days
Other illness
- Diabetes
- Uncontrolled hypertension
- History of seizures
- History of glaucoma
- History of chronic kidney disease
Other
- Engagement with vomiting or laxative use within the last 28 days with the aim of controlling their shape or weight
- Lost weight \>11 lbs in the last 90 days
- Pregnant, breastfeeding, intends to become pregnant, of child-bearing potential and not using a highly effective contraceptive method
- Any other reason rendering a participant unsuitable for trial participation, as determined by a clinician or study investigator
Who the study is looking for
- BMI of \>30 or BMI of \>27 with one or more weight related medically qualifying condition (hypertension, dyslipidemia, sleep apnea, cardiovascular disease)
- Determined eligible for Bupropion/Naltrexone or Liraglutide by WW Clinic medical provider and initiated a medication management plan
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| WW International, Inc Coordinator of this site? Confirm its status | New York | United States | Unknown status |
Related publications
- Efficacy of Oral Antiobesity Medications With Versus Without Adjunct Behavioral Weight Management Treatment.Obesity (Silver Spring) · 2026 · PMID 41703970
This page is information, not medical advice. Discuss any trial with your doctor.